About Us

Luye Pharma Group (02186.HK), a member of Luye Life Sciences Group, is an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications.

On The Road

Registration Application of Luye Pharma’s New Drug for Parkinson’s Disease Accepted by China’s NMPA

News

Luye Pharma Group has announced that its application to register Pramipexole Dihydrochloride Sustained Release Tablet for the treatment of Parkinson's disease has been accepted by China’s National Medical Products Administration ...

April 10,2019

Luye Pharma’s Rykindo® Expected to Be the First Chinese Innovative Drug to Receive U.S. FDA Approval

Luye Pharma Group has announced submission of a new drug application (NDA) to the U.S. Food and Drug Administration (“FDA”) for Rykindo®, completed on March 28. Rykindo® (LY03004) Risperidone Extended-release Microsphere ...

March 29,2019

Read More

Investors

Employee Stories

Upholding the philosophy of “Employee Development”,
Luye Pharma regards employees as the most valuable resources of the company